Two polymorphisms in the fracalkine receptor CX3CR1 are not associated with peripheral arterial disease
- 1 February 2003
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 166 (2) , 339-343
- https://doi.org/10.1016/s0021-9150(02)00362-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Adhesion molecules and their role in vascular diseaseAmerican Journal of Hypertension, 2001
- Linked Chromosome 16q13 Chemokines, Macrophage-Derived Chemokine, Fractalkine, and Thymus- and Activation-Regulated Chemokine, Are Expressed in Human Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Chemokine receptors and their role in inflammation and infectious diseasesBlood, 2000
- CX3C-Chemokine, Fractalkine-Enhanced Adhesion of THP-1 Cells to Endothelial Cells Through Integrin-Dependent and -Independent MechanismsThe Journal of Immunology, 2000
- The role of fractalkine in the recruitment of monocytes to the endotheliumEuropean Journal of Pharmacology, 2000
- Chemokines and atherosclerosisAtherosclerosis, 1999
- Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and AdhesionPublished by Elsevier ,1997
- Cytokine regulation of endothelial cell function: from molecular level to the bedsideImmunology Today, 1997
- A new class of membrane-bound chemokine with a CX3C motifNature, 1997
- The Molecular Biology of Leukocyte Chemoattractant ReceptorsAnnual Review of Immunology, 1994